Goehring & Rozencwajg Associates LLC increased its holdings in shares of Nutrien Ltd. (NYSE:NTR – Free Report) by 9.4% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 203,183 shares of the company’s stock after acquiring an additional 17,500 shares during the quarter. Nutrien comprises 2.1% of Goehring & Rozencwajg Associates LLC’s portfolio, making the stock its 17th biggest holding. Goehring & Rozencwajg Associates LLC’s holdings in Nutrien were worth $10,344,000 as of its most recent SEC filing.
A number of other institutional investors have also made changes to their positions in NTR. Family Firm Inc. acquired a new position in shares of Nutrien during the 2nd quarter worth approximately $32,000. GoalVest Advisory LLC acquired a new position in shares of Nutrien during the 1st quarter worth approximately $35,000. Trust Co. of Vermont increased its holdings in shares of Nutrien by 50.0% during the 2nd quarter. Trust Co. of Vermont now owns 900 shares of the company’s stock worth $46,000 after acquiring an additional 300 shares during the last quarter. Covestor Ltd increased its holdings in shares of Nutrien by 33.3% during the 1st quarter. Covestor Ltd now owns 932 shares of the company’s stock worth $50,000 after acquiring an additional 233 shares during the last quarter. Finally, Andra AP fonden acquired a new position in Nutrien in the 2nd quarter valued at $51,000. 63.10% of the stock is owned by institutional investors and hedge funds.
Nutrien Price Performance
Shares of NTR stock opened at $46.82 on Thursday. The company has a quick ratio of 0.82, a current ratio of 1.26 and a debt-to-equity ratio of 0.37. Nutrien Ltd. has a twelve month low of $44.65 and a twelve month high of $64.29. The company has a market cap of $23.16 billion, a P/E ratio of 27.38, a P/E/G ratio of 1.51 and a beta of 0.82. The business has a fifty day simple moving average of $48.09 and a 200 day simple moving average of $51.91.
Nutrien Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Friday, October 18th. Shareholders of record on Friday, September 27th will be given a $0.54 dividend. The ex-dividend date of this dividend is Friday, September 27th. This represents a $2.16 annualized dividend and a yield of 4.61%. Nutrien’s dividend payout ratio is presently 126.32%.
Wall Street Analysts Forecast Growth
NTR has been the topic of a number of research reports. The Goldman Sachs Group lowered Nutrien from a “buy” rating to a “neutral” rating and decreased their price objective for the company from $69.00 to $53.00 in a report on Tuesday, September 10th. Hsbc Global Res lowered Nutrien from a “hold” rating to a “moderate sell” rating in a report on Friday, August 2nd. Wells Fargo & Company decreased their price objective on Nutrien from $68.00 to $66.00 and set an “overweight” rating on the stock in a report on Tuesday, July 16th. Mizuho decreased their price objective on Nutrien from $55.00 to $52.00 and set a “neutral” rating on the stock in a report on Thursday, August 8th. Finally, Royal Bank of Canada reaffirmed an “outperform” rating and issued a $60.00 price objective on shares of Nutrien in a report on Monday, August 12th. Three equities research analysts have rated the stock with a sell rating, four have issued a hold rating and twelve have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $62.39.
About Nutrien
Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.
See Also
- Five stocks we like better than Nutrien
- 3 Warren Buffett Stocks to Buy Now
- Why General Mills Is the Perfect Hedge for S&P 500 Volatility
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Viking Therapeutics Is Having a Year to Remember: Time to Buy?
- Most active stocks: Dollar volume vs share volume
- Leverage Proven Stock Factors With These Top 3 Smart Beta ETFs
Want to see what other hedge funds are holding NTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nutrien Ltd. (NYSE:NTR – Free Report).
Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.